REBECCA POWELL: Open Payments
NPI 1568765774 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 45 payments from 19 companies in 2025. Trend: 2023 $58 · 2024 $808 · 2025 $1,406
Food & beverage: $1,406
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $281 |
| Boston Scientific Corporation | 2 | $174 |
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| CARDIVA MEDICAL, INC. | 1 | $125 |
| Amgen Inc. | 6 | $115 |
| Medtronic, Inc. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Edwards Lifesciences Corporation | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Philips North America LLC | 1 | $31 |
Products named: WATCHMAN FLX, BREZTRI, CARDIVA VASCADE MVP XL VVCS 10-12F, CAMZYOS, REPATHA, MICRA, LEQVIO, SAPIEN 3 Ultra RESILIA.
Industry payments across GA — which companies pay providers there.
